Delayed Diagnosis of Transthyretin Cardiac Amyloidosis Is Associated With Heart Failure Hospitalizations and Mortality

By afschroeder • July 23, 2026

Spencer-Bonilla G, Fan J, Varshney AS, Cheng P, Din N, Rodriguez F, Davies M, Papas MA, Huang J, Venditto J, Witteles RM, Heidenreich P, Alexander K, Sandhu AT. Delayed Diagnosis of Transthyretin Cardiac Amyloidosis Is Associated With Heart Failure Hospitalizations and Mortality. JACC Adv. 2026 Jul 22;5(8):103019. doi: 10.1016/j.jacadv.2026.103019. Epub ahead of print. PMID: 42485712.

Tags: amyloidosis, Cardiology/Epi, cardiomyopathy, diagnostic delay, Publications, Transthyretin, Veterans Administration

Related Posts

Pregnancy damps thermoregulatory rhythms across timescales through neural estrogen signaling in mice

Cortes LR, Xiong L, Vree AR, Reis FMCV, Kim N, Feng B, Hansen MR, Rashid S, Sandoval NP, Lopez JI, He Y, Adhikari A, van[...]

MAGGIC and PREDICT-HF Models in the VICTOR Trial: Do Traditional Risk Scores Still Work in Well-Treated Ambulatory Patients with HFrEF?

Senni M, Butler J, Cyr D, Anstrom KJ, Barash I, Bonaca MP, Budoff M, Cho MC, Crespo-Leiro MG, Corda S, Ezekowitz J, Lam CSP, Lewis[...]

Artificial intelligence-derived splenic response in cardiac positron emission tomography is associated with major adverse cardiovascular events: a multi-site study

Ramirez G, Dharmavaram NL, Shanbhag A, Miller RJH, Kavanagh PB, Yi J, Lemley M, Builoff V, Marcinkiewicz A, Dey D, Hainer J, Wopperer S, Knight[...]